Table 3.
REC variation in the cohort of patients without relapse according to subtype.
| REC baseline | REC post-surgery | REC 1y Follow-up |
REC 2y follow-up | REC 5y follow-up | REC 10y follow-up | Friedman test | ||
|---|---|---|---|---|---|---|---|---|
| Luminal A | N | 325 | 225 | 243 | 239 | 188 | 91 | |
| Median | 1.8% | 2.7% | 2.6% | 2.7% | 2.6% | 2.6% | < 0.0001 | |
| SD | 1.882 | 2.580 | 1.710 | 1.757 | 1.578 | 1.733 | ||
| Luminal B | N | 236 | 181 | 206 | 187 | 129 | 45 | |
| Median | 1.6% | 2.5% | 2.8% | 2.5% | 2.9% | 2.5% | < 0.0001 | |
| SD | 1.666 | 2.231 | 2.299 | 2.267 | 1.510 | 1,405 | ||
| HER2-enriched | N | 50 | 35 | 39 | 32 | 23 | 12 | |
| Median | 1.8% | 2.8% | 2.8% | 2.1% | 2.7% | 3.4% | <0.0001 | |
| SD | 3.573 | 2.352 | 2.028 | 1.147 | 1.360 | 1.309 | ||
| TNBC | N | 115 | 81 | 102 | 89 | 62 | 19 | |
| Median | 1.4% | 2.8% | 2.5% | 2.4% | 2.1% | 2.7% | < 0.0001 | |
| SD | 1.502 | 2.190 | 1.680 | 1.364 | 1.430 | 2.945 |
Abbreviations: REC, Relative Eosinophil Count; y, years; N, Number; SD, Standard Deviation; TNBC, Triple-Negative Breast Cancer.